Unknown

Dataset Information

Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.


ABSTRACT:

Background

Low myocardial cGMP-PKG (cyclic guanosine monophosphate-protein kinase G) activity has been associated with increased cardiomyocyte diastolic stiffness in heart failure with preserved ejection fraction. Cyclic guanosine monophosphate is mainly hydrolyzed by PDE (phosphodiesterases) 5a and 9a. Importantly, PDE9a expression has been reported to be upregulated in human heart failure with preserved ejection fraction myocardium and chronic administration of a PDE9a inhibitor reverses preestablished cardiac hypertrophy and systolic dysfunction in mice subjected to transverse aortic constriction (TAC). We hypothesized that inhibiting PDE9a activity ameliorates diastolic dysfunction.

Methods

To examine the effect of chronic PDE9a inhibition, 2 diastolic dysfunction mouse

SUBMITTER: Methawasin M 

PROVIDER: S-EPMC7895451 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature